Abstract
Objectives: The risk of cognitive impairment is a concern for patients with major depressive disorder receiving electroconvulsive therapy (ECT). Here, we evaluate the acute, short-term and long-term effects of ECT on tests of processing speed, executive function, memory, and attention. Methods: Forty-four patients with major depressive disorder receiving ECT (61% right unilateral, 39% mixed right unilateral-bitemporal, left unilateral, and/or bitemporal lead placement) underwent a cognitive battery prior to ECT (T1), after 2 sessions (T2), and at the end of the index (T3). Thirty-two patients returned for a 6-month follow-up (T4). Thirty-three control subjects were assessed at 2 times approximately 4 weeks apart (C1 and C2). Results: At baseline, patients showed deficits in processing speed, executive function, and memory compared with control subjects. Including depression severity and lead placement covariates, linear mixed-model analysis showed significant improvement in only processing speed between T1 and T3 and between T1 and T4 in patients. An acute decline in attention and verbal memory was observed at T2, but performance returned to baseline levels at T3. Longitudinal cognitive outcomes did not differ in patients defined as ECT responders/nonresponders. Limitations Episodic memory was not measured, and medications were not controlled between T3 and T4. Control subjects also showed improvements in processing speed, suggesting practice effects for some measures. Conclusions: In this naturalistic ECT treatment study, results show that the initiation of ECT may transiently affect memory and executive function, but cognition is largely unaffected during and after ECT. Whereas some functions might improve, others will at least remain stable up to 6 months following the ECT index.
Original language | English (US) |
---|---|
Pages (from-to) | 278-285 |
Number of pages | 8 |
Journal | Journal of ECT |
Volume | 33 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1 2017 |
Funding
From the *Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, and †Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA. Received for publication November 28, 2016; accepted April 14, 2017. Reprints: Randall Espinoza, MD, MPH, 300 UCLA Medical Plaza, Suite 2235, University of California Los Angeles, Los Angeles, CA 90095 (e‐mail: [email protected]). Funding for this study was provided by the National Institute of Mental Health through award R01MH092301. The authors have no conflicts of interest or financial disclosures to report. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved. DOI: 10.1097/YCT.0000000000000426
Keywords
- cognition
- electroconvulsive therapy
- major depressive disorder
ASJC Scopus subject areas
- Neuroscience (miscellaneous)
- Psychiatry and Mental health